<DOC>
	<DOCNO>NCT02034058</DOCNO>
	<brief_summary>The primary objective study evaluate rate stroke and/or death patient treat Wingspan Stent System , accord Indications Use , within 72 hour post procedure .</brief_summary>
	<brief_title>Post Market Surveillance Study Wingspan Stent System</brief_title>
	<detailed_description>This research study Food Drug Administration ( FDA ) mandate post market surveillance study Wingspan® Stent System , also know WEAVE™ Trial . The purpose trial fulfill FDA requirement evaluate rate stroke and/or death within 72 hour procedure , patient Wingspan Stent implant accordance Indications Use .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Intracranial Arteriosclerosis</mesh_term>
	<criteria>All patient treatment Wingspan Stent System consider .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Wingspan Stent System</keyword>
	<keyword>Wingspan Stent</keyword>
	<keyword>Intracranial Stent</keyword>
	<keyword>Ischemic Stroke</keyword>
	<keyword>Intracranial Atherosclerotic Disease</keyword>
	<keyword>Intracranial Stenosis</keyword>
</DOC>